Angiolink privately held medical device company focused on developing innovative wound closure solutions for vascular procedures.
Angiolink Corporation offers EVS vascular closure system, an arterial stapling device for use in closing holes and punctures made in arteries in connection with the catheter-based surgical procedures, such as angioplasty and angiograms.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 10, 2003 | Series B | $13.60M | 1 | — | — | Detail |
Sep 17, 2002 | Series A | $10.60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Boston Financial & Equity Corporation | — | Series B |